Model Number C0R47 |
Device Problem
Device Dislodged or Dislocated (2923)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 04/01/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
(b)(4) has received the incident device and has been assigned to engineering for evaluation.A follow-up report will be sent upon completion of investigation.In accordance to 21 cfr 803.56, if we obtain additional information, which was not known or was not available when the initial report was submitted, then the supplemental report will be submitted to the fda.There is no report of serious injury or death associated with this event.
|
|
Event Description
|
Procedure performed unknown - "this is a complaint from the market.Administrative no.(b)(4).Please refer to the complaint sheet for investigation." complaint sheet - report from the sales rep: the seal dislodged from the cannula.Initial investigation report by (b)(4) olympus: the event unit was returned to olympus and visually inspected: the seal did not come off when pulled with the latch tabs not pressed; the latch tabs were not deformed.The unit will be returned to (b)(4) for further evaluation.Admin#(b)(4)." patient status - no patient injury.
|
|
Manufacturer Narrative
|
Investigation summary: the event unit was returned for evaluation.Engineering was able to confirm the customer's experience of the seal being dislodged from the cannula; they noted that the seal could be dislodged from the cannula without pressing the latch tabs.The distance between the latch tabs was measured and was found to be out of specification.During the manufacturing process, all trocars are thoroughly inspected for functionality and performance prior to packaging.The root cause of the event is likely due to the distance between the two tabs not meeting specifications.Applied medical has opened a corrective and preventative action (capa) to further elevate and track this investigation and implement appropriate corrective actions to mitigate this type of event.In accordance with 21 cfr 803.56, if additional information is obtained which was not known or was not available when this report was submitted, then a supplemental report will be submitted to the fda.
|
|
Search Alerts/Recalls
|